Introducing #
APCCC26# Live from Lugano🇨🇭Brought to you from APCCC together with
@OncoAlert 🚨
Triplet vs Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer | APCCC 2026 Expert Discussion
Join Dr. Jones, Dr. Rathkopf, and Dr. Fizazi for an expert discussion on one of the most rapidly evolving questions in genitourinary oncology: the optimal treatment approach for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Series Faculty
@BertrandTOMBAL @ChrisSweens1 @jmmrad
@drjefstathiou @CaPsurvivorship @LoebStacy
@charlesryanmd @AarmstrongDuke @Ecastromarcos
@LVM_Walz @piet_ost @Nicola_Fossati @AnthonyMJoshua @Prof_Nick_James @VedangMurthy
@AttardLab @Silke_Gillessen @AOmlin
Pinging
@AmandaNizamMD @scocmem @nataliagandur
@gu_onc @tompowles1 @brian_rini @declangmurphy
@cdanicas @neerajaiims